Stockscreener 앱 받기
117.61
0.14%
-0.16
시장 영업 전:
118.02
0.41
+0.35%
전일 마감가:
$117.77
열려 있는:
$119
하루 거래량:
2.54M
Relative Volume:
1.06
시가총액:
$14.22B
수익:
$7.10B
순이익/손실:
$824.00M
주가수익비율:
18.03
EPS:
6.5244
순현금흐름:
$761.00M
1주 성능:
+7.21%
1개월 성능:
+16.12%
6개월 성능:
-6.19%
1년 성능:
-19.42%
1일 변동 폭
$116.75
$120.87
1주일 범위
$110.47
$120.87
52주 변동 폭
$96.66
$159.04
클로락스 Stock (CLX) Company Profile
명칭
Clorox Co
전화
(510) 271-7000
주소
THE CLOROX COMPANY, OAKLAND, CA
Compare CLX vs PG, UL, CL, EL, KVUE
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLX
Clorox Co
|
117.61 | 14.24B | 7.10B | 824.00M | 761.00M | 6.5244 |
|
PG
Procter Gamble Co
|
158.61 | 364.57B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
71.57 | 154.37B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
94.88 | 76.07B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
96.66 | 43.10B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KVUE
Kenvue Inc
|
18.07 | 34.51B | 15.01B | 1.43B | 1.63B | 0.744 |
클로락스 Stock (CLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-01 | 재확인 | Barclays | Underweight |
| 2025-01-07 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-11-06 | 업그레이드 | TD Cowen | Sell → Hold |
| 2024-10-01 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-07-23 | 개시 | TD Cowen | Sell |
| 2024-06-24 | 개시 | Exane BNP Paribas | Underperform |
| 2024-04-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-03-26 | 업그레이드 | Jefferies | Underperform → Hold |
| 2024-03-01 | 재개 | Goldman | Sell |
| 2024-02-05 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2023-12-15 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-11-22 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-11-13 | 개시 | Jefferies | Underperform |
| 2023-11-06 | 업그레이드 | UBS | Sell → Neutral |
| 2023-11-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-10-12 | 업그레이드 | Bernstein | Underperform → Mkt Perform |
| 2023-10-05 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-10-02 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2023-09-22 | 개시 | HSBC Securities | Hold |
| 2023-08-03 | 업그레이드 | Atlantic Equities | Underweight → Neutral |
| 2023-02-17 | 개시 | Citigroup | Neutral |
| 2022-10-18 | 개시 | Evercore ISI | Underperform |
| 2022-10-17 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | 재개 | BofA Securities | Underperform |
| 2022-07-13 | 개시 | Raymond James | Outperform |
| 2022-02-04 | 다운그레이드 | Atlantic Equities | Neutral → Underweight |
| 2022-02-04 | 재확인 | Deutsche Bank | Hold |
| 2022-02-04 | 재확인 | JP Morgan | Underweight |
| 2022-02-04 | 재확인 | Morgan Stanley | Underweight |
| 2022-02-04 | 재확인 | UBS | Sell |
| 2022-02-04 | 재확인 | Wells Fargo | Underweight |
| 2022-02-02 | 다운그레이드 | Bernstein | Mkt Perform → Underperform |
| 2022-01-26 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2021-11-02 | 재확인 | DA Davidson | Neutral |
| 2021-11-02 | 재확인 | Deutsche Bank | Hold |
| 2021-11-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-11-02 | 재확인 | Wells Fargo | Underweight |
| 2021-09-03 | 다운그레이드 | Argus | Buy → Hold |
| 2021-08-04 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2021-08-04 | 재확인 | Citigroup | Buy |
| 2021-08-04 | 재확인 | Credit Suisse | Neutral |
| 2021-08-04 | 재확인 | Deutsche Bank | Hold |
| 2021-08-04 | 재확인 | Morgan Stanley | Underweight |
| 2021-08-04 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2021-08-04 | 재확인 | UBS | Sell |
| 2021-08-04 | 재확인 | Wells Fargo | Underweight |
| 2021-06-24 | 개시 | UBS | Sell |
| 2021-05-03 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2021-03-18 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2021-02-19 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2021-01-20 | 개시 | Bernstein | Mkt Perform |
| 2020-12-14 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-12-08 | 개시 | Wells Fargo | Overweight |
| 2020-10-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-06-30 | 개시 | DA Davidson | Buy |
| 2020-03-19 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2020-03-16 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2020-03-09 | 업그레이드 | Argus | Hold → Buy |
| 2019-10-03 | 재확인 | BofA/Merrill | Neutral |
| 2019-09-23 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2019-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2019-05-02 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-02 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2019-04-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-03-07 | 개시 | Credit Suisse | Outperform |
| 2018-12-06 | 재확인 | BofA/Merrill | Neutral |
| 2018-09-25 | 업그레이드 | Argus | Hold → Buy |
| 2018-07-18 | 다운그레이드 | Goldman | Neutral → Sell |
| 2018-04-19 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-02-08 | 다운그레이드 | Argus | Buy → Hold |
| 2018-01-04 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
모두보기
클로락스 주식(CLX)의 최신 뉴스
Clorox Posts Mixed Quarterly Results Amid Strategic Acquisition - AD HOC NEWS
TD Cowen Issues Positive Forecast for Clorox (NYSE:CLX) Stock Price - MarketBeat
BofA flags margin uncertainty for Clorox (CLX) after Q2 earnings miss - MSN
BofA Flags Margin Uncertainty for Clorox (CLX) After Q2 Earnings Miss - Finviz
Clorox Weighs GOJO Deal And ERP Payoff For Growth Reboot - simplywall.st
Morgan Stanley Increases Clorox (NYSE:CLX) Price Target to $136.00 - MarketBeat
The Clorox Company $CLX Stake Lifted by Ashton Thomas Private Wealth LLC - MarketBeat
Clorox Stock Scrubs Out Its Stain: Is This Household Giant Finally Turning the Corner? - AD HOC NEWS
Clorox to Present at 2026 CAGNY Conference - Finviz
Clorox completes $580 million ERP overhaul to link operations with digital commerce - Digital Commerce 360
Clorox Completes U.S, Canada ERP Upgrade - Consumer Goods Technology
UBS Raises Price Target for Clorox (CLX) Amidst Neutral Rating | - GuruFocus
Citigroup Raises Clorox (CLX) Price Target to $115.00, Maintains Neutral Rating | CLX Stock News - GuruFocus
Akron’s GOJO Industries is ‘strong, strategic fit’ with Clorox, CEO says - Signal Akron
Is Clorox’s ERP Strain And GOJO Deal Altering The Investment Case For Clorox (CLX)? - simplywall.st
CLX Analyst Rating Update: JP Morgan Maintains Neutral, Raises P - GuruFocus
Clorox (CLX) Analyst Rating: Evercore Lowers Price Target | CLX Stock News - GuruFocus
Deutsche Bank Aktiengesellschaft Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price - MarketBeat
Clorox (NYSE:CLX) Price Target Cut to $151.00 by Analysts at Jefferies Financial Group - MarketBeat
Clorox (NYSE:CLX) Price Target Raised to $117.00 at JPMorgan Chase & Co. - MarketBeat
Jefferies & Co Adjusts Clorox Price Target to $151 From $152, Maintains Buy Rating - marketscreener.com
The Clorox Company (NYSE:CLX) Q2 2026 Earnings Call Transcript - Insider Monkey
Why Is Clorox Stock Falling Wednesday?Clorox (NYSE:CLX) - Benzinga
CLX Q4 Deep Dive: Flat Sales Amid Margin Pressure as Clorox Invests in Innovation and Integration - Finviz
Clorox Co (CLX) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic Innovation and Growth Plans - GuruFocus
Decoding Clorox Co (CLX): A Strategic SWOT Insight - GuruFocus
The Clorox Company (CLX): A bull case theory - MSN
The Clorox Company (CLX): A Bull Case Theory - Insider Monkey
Clorox's (NYSE:CLX) Q4 CY2025: Beats On Revenue - Finviz
Clorox: Fiscal Q2 Earnings Snapshot - theheraldreview.com
Clorox to Acquire GOJO Industries, Makers of Purell® - cmmonline.com
Clorox (CLX) misses Q2 earnings estimates - MSN
Clorox (CLX) Q2 Earnings Miss Expectations, Revenue Surpasses Es - GuruFocus
Earnings call transcript: Clorox Q2 2026 sees mixed results and stock dip - Investing.com
Clorox: Overview of Fiscal Second Quarter Earnings - Bitget
CLOROX CO /DE/ SEC 10-Q Report - TradingView
Clorox Earnings Review: Q2 Summary - Benzinga
Clorox (NYSE:CLX) Posts Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat
Transforming our operations: Clorox completes ERP rollout across US and Canada - The Clorox Company
Clorox shares slip 2% as Q2 earnings miss overshadows revenue beat, driven by higher costs - Investing.com Nigeria
Chair and CEO Linda Rendle on Q2 earnings and outlook for FY26 - The Clorox Company
Clorox’s (NYSE:CLX) Q4 CY2025: Beats On Revenue - The Globe and Mail
Clorox misses quarterly profit estimates on muted demand for its cleaning products, higher costs - Reuters
Layoff Watch: What are Cyclerion Therapeutics Inc.’s technical support levelsJuly 2025 Sentiment & Short-Term High Return Ideas - baoquankhu1.vn
Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook - Yahoo Finance
Clorox Settles Male Worker's Gender Bias Suit On Eve Of Trial - Law360
Clorox (CLX) Sees Normal Pre-Earnings Options Activity with Calls Outpacing Puts - GuruFocus
Clorox (CLX) Leads Consumer Staples Stocks with Strong YTD Perfo - GuruFocus
Clorox fined $14.15M for delayed warning about Pine-Sol bacteria - MSN
I Tried the New Clorox Sink Mat With a Rinse Rack—Here’s Why It Works So Well - Dengarden
Clorox earnings on deck as GOJO deal reshapes growth outlook - Investing.com
클로락스 (CLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.18%
0.01%
자본화:
|
볼륨(24시간):